Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Amgen News

Home | Index > Business & Companies > Nasdaq 100 > Amgen

TAKE THIS POLL
Is Belgian Prime Minister Herman Van Rompuy the right person to lead the EU as its president? (Nov. 20, 2009) Yes. No. Don't know.

Sort by: relevance (24 hours) relevance date

PRIMECAP Management Top Purchases: AMGN, BA, ERIC, ERTS, LLY 24 Nov 2009 05:17 GMT
... is the list of ), Add: 0.32% of the portfolio - Total: 39,278,616 Shares Amgen Inc. is a biotechnology company that discovers, develops, manufactures and markets human therapeutics-based on ...
Four Senior Executives Join Orexigen Therapeutics Management Team 24 Nov 2009 14:15 GMT
... and diabetes pipeline. Previously, Viveash was Vice President of Regulatory Affairs and Safety at Amgen and Vice President of Regulatory Affairs, Safety and Professional Services at Immunex. Through her ...
Coping with Appearance-Related Side Effects of EGFR Inhibitor Treatment 24 Nov 2009 12:52 GMT
... the nursing community, ONS —a subsidiary of the Oncology Nursing Society—and the pharmaceutical company Amgen (manufacturer of the EGFR inhibitor Vectibix, a formulation of panitumumab) planned and produced an ...
Home sales surge thanks to tax incentive for... 24 Nov 2009 08:46 GMT
... as head of managed markets and government affairs. Preston Klassen, formerly of Thousand Oaks-based Amgen, joins as head of the global Contrave program. Whedy Wang, who worked for Gilead ...
US patient groups launch matching service for lung cancer trials 24 Nov 2009 10:53 GMT
... number of pharmaceutical companies active in the lung cancer field, namely Boehringer Ingelheim Pharmaceuticals, Amgen, AstraZeneca, Genentech BioOncology and Pfizer Oncology. to read the rest of today’s Clinical News ...

Artel to Launch New Technology at LabAutomation2010 24 Nov 2009 14:12 GMT
... of laboratories including pharmaceutical, clinical, forensic, public health and environmental. Leading institutions such as Amgen, ARUP, Bristol-Myers Squibb, Celgene, Centers for Disease Control, DuPont, Eli Lilly, FBI, Genentech, Genomic ...
First-of-its-Kind Collaboration Among Advocacy Groups Provides Lung Cancer Patients Personalized Information About Clinical Trials 24 Nov 2009 14:54 GMT
... support for the Lung Cancer Clinical Trial Call to Action campaign and matching service: Amgen Inc., AstraZeneca, Genentech BioOncology, and Pfizer Oncology. Lung cancer is the world's most common ...
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition 24 Nov 2009 15:30 GMT
... being conducted by Genentech and Roche. Other ImmunoGen collaborative partners include Bayer HealthCare and Amgen. More information about ImmunoGen can be found at This press release includes forward-looking statements. ...
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Expositi 24 Nov 2009 15:32 GMT
... being conducted by Genentech and Roche. Other ImmunoGen collaborative partners include Bayer HealthCare and Amgen. More information about ImmunoGen can be found at This press release includes forward-looking statements. ...
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 23 Nov 2009 20:30 GMT
... THOUSAND OAKS, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

Amgen Recognized for Best Pipeline and Best New Drug at Scrip... 23 Nov 2009 20:55 GMT
... THOUSAND OAKS, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Amgen was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for ...
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards (PRN) 23 Nov 2009 20:33 GMT
... "We are very pleased to be honored by our industry peers with these two awards," said ...
Four Senior Executives Join Orexigen(R) Therapeutics Management Team 23 Nov 2009 14:03 GMT
... and diabetes pipeline. Previously, Viveash was Vice President of Regulatory Affairs and Safety at Amgen and Vice President of Regulatory Affairs, Safety and Professional Services at Immunex. Through her ...
Special Sessions Announced For World Congress On Osteoporosis 2010 - IOF WCO - ECCEO10 23 Nov 2009 08:40 GMT
... 2010 IOF-Servier Young Investigator Award NEW: Deadline extended to February 1, 2010 ESCEO - Amgen Osteoporosis Fellowship Program 2010 Deadline for applications: March 8, 2010 IOF WCO- ECCEO10 Florence, ...
Gene Silencing To Boost Biological Drug Yields 23 Nov 2009 10:50 GMT
... market estimated to be worth about 100 billion US dollars. For instance, top-sellers like Amgen Inc's are made using CHO cell lines, reported Bloomberg. RNAi is a new approach ...
Cytokinetics to Present Non-Clinical Data From Its Smooth Muscle Contractility Program at the 2009 S 23 Nov 2009 10:51 GMT
... CK-1827452), is in Phase II clinical development for the potential treatment of heart failure. Amgen Inc. holds an exclusive license worldwide (excluding Japan) to develop and commercialize omecamtiv mecarbil ...
Winners, Losers in Senate Health Bill 23 Nov 2009 15:52 GMT
... Medicare advisory board, sparing them from future potential payment cuts. Biological drugmakers such as Amgen Inc, Roche's Genentech unit maintained their 12-year period of exclusive sales for brand-name drugs ...
Tan Le Joins Miller Zell 23 Nov 2009 17:50 GMT
... and global brands including T-Mobile, 3M, Banana Republic, the NBA, General Mills, Microsoft, Nintendo, Amgen and Alaska Airlines. ...
Vioxx Trial Data Shows Early Cardiovascular Risk, 23 Nov 2009 23:52 GMT
... Foundation for Medical Care; has previously served on the advisory boards of Alere and Amgen, and currently serves on one with UnitedHealthcare; is a scientific advisor for Centegen; has ...
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Company's TAP Technology 19 Nov 2009 21:32 GMT
... ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Company's TAP Technology . (Nasdaq: IMGN), a biotechnology company ...

THESE STORIES ARE NOT PUBLISHED BY IPD GROUP, INC. AND THESE LINKS WILL TAKE YOU TO OTHER WEBSITES. SOME OF THESE WEBSITES REQUIRE THEIR OWN REGISTRATION TO READ THEIR STORIES. PLEASE READ THE DISCLAIMER FOR MORE DETAILS. >>>

Proteomics: Research reports from Amgen, Inc. provide new insights into proteomics 18 Nov 2009 05:54 GMT
... mass spectrometry to that determined by a fluorescence-based method," wrote Z.Q. Zhang and colleagues, Amgen, Inc. The researchers concluded: "This large-scale method may potentially replace many chromatographic methods for ...
Amgen bags awards for best pipeline and for Nplate 19 Nov 2009 11:57 GMT
... Amgen bags awards for best pipeline and for Nplate Amgen is celebrating after winning overall ...
PRIMECAP Management Top Holdings: Amgen Inc., Eli Lilly and Company, Novartis AG, FedEx Corp., Google Inc., Medtronic Inc. 22 Nov 2009 16:16 GMT
... on Utilities and Telecommuniations. As of individual holdings, here are the firm’s top holdings: Amgen Inc. is a biotechnology company that discovers, develops, manufactures and markets human therapeutics-based on ...
PRIMECAP Management Top Purchases: Amgen Inc., The Boeing Company, Telefonaktiebolaget LM Ericsson Telephone Company, Electronic Arts Inc., Eli Lilly and Company 22 Nov 2009 16:16 GMT
... is the list of ), Add: 0.32% of the portfolio - Total: 39,278,616 Shares Amgen Inc. is a biotechnology company that discovers, develops, manufactures and markets human therapeutics-based on ...
Second license deal with Amgen to bring ImmunoGen another $35M 20 Nov 2009 15:33 GMT
... Waltham biotechnology firm ImmunoGen Inc. has announced a second license granted to Amgen Inc. for its maytansinoid Targeted Antibody Payload technology for an undisclosed target. The deal ...